Nudge secures $100M Series A for focused-ultrasound brain interface

Nudge raised a $100M Series A led by Thrive Capital and Greenoaks. The funding supports commercialization of Nudge Zero, which uses focused ultrasound to stimulate deep brain circuits without surgery, with millimeter precision guided by MRI. The device is in human research trials for conditions including essential tremor and chronic pain.